Terumo Corporation, a Tokyo-based medical device company, has announced that it will acquire Sequent Medical, Inc, a privately-held firm developing a new medical device for aneurysm embolisation, for $280 million.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
